Alkami Technology, Inc. (ALKT)

ShockWave Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	52.43	94.36	40.93	108.72	308.58	166.79
Short-Term Investments	34.69	21.38	51.2	87.64	-	-
Cash & Short-Term Investments	87.11	115.73	92.12	196.36	308.58	166.79
Cash Growth	-0.32%	25.63%	-53.08%	-36.37%	85.01%	1292.00%
Accounts Receivable	47.68	38.74	35.5	25.5	19.47	13.4
Other Receivables	-	-	-	0.75	1.36	0.7
Receivables	47.68	38.74	35.5	26.25	20.82	14.1
Prepaid Expenses	28.41	13.7	10.63	8.09	6.11	6.2
Restricted Cash	-	-	-	3.62	3.37	-
Other Current Assets	14.63	13.21	10.33	7.86	6.27	6.15
Total Current Assets	177.83	181.38	148.59	242.17	345.16	193.24
Property, Plant & Equipment	38.4	36.64	32.7	28.23	11.83	10.46
Goodwill	403.81	148.05	148.05	148.02	48.09	16.22
Other Intangible Assets	172.18	29.02	35.81	42.59	11.16	8.27
Long-Term Accounts Receivable	-	1.9	1.5	0.5	0.7	0.8
Long-Term Deferred Charges	38.52	37.18	30.73	24.78	17.99	14.86
Other Long-Term Assets	9.64	3.11	2.45	2.6	1.58	5.33
Total Assets	840.39	437.28	399.83	488.89	436.51	249.17
Accounts Payable	6.7	6.13	7.48	4.29	3.65	0.36
Accrued Expenses	30.97	23.44	17.94	16.6	12.73	8.72
Current Portion of Long-Term Debt	-	-	-	3.19	1.56	0.31
Current Portion of Leases	1.58	1.34	1.21	3.66	-	-
Current Income Taxes Payable	-	0.63	1.17	1.15	3.72	2.39
Current Unearned Revenue	27.16	13.58	10.98	8.84	8.2	6.12
Other Current Liabilities	-	0.44	0.66	3.9	3.33	2.58
Total Current Liabilities	66.41	45.57	39.43	41.61	33.2	20.48
Long-Term Debt	385.21	-	-	81.39	23.05	24.57
Long-Term Leases	16.51	17.11	18.05	15.82	-	-
Long-Term Unearned Revenue	25.6	15.53	15.38	13.9	13.87	14.42
Long-Term Deferred Tax Liabilities	2.41	1.82	1.71	1.71	0.09	-
Other Long-Term Liabilities	0.23	0.22	0.31	0.4	21.69	9.95
Total Liabilities	496.37	80.25	74.88	154.84	91.9	69.43
Common Stock	0.1	0.1	0.1	0.09	0.09	0.01
Additional Paid-In Capital	841.52	833.13	760.21	706.41	658.37	-
Retained Earnings	-497.61	-476.2	-435.37	-372.45	-313.85	-263.53
Total Common Equity	344.02	357.03	324.94	334.05	344.61	-263.52
Shareholders' Equity	344.02	357.03	324.94	334.05	344.61	179.74
Total Liabilities & Equity	840.39	437.28	399.83	488.89	436.51	249.17
Total Debt	403.31	18.45	19.26	104.05	24.62	24.88
Net Cash (Debt)	-316.19	97.28	72.87	92.3	283.97	141.91
Net Cash Growth	-	33.51%	-21.06%	-67.50%	100.10%	1085.46%
Net Cash Per Share	-3.11	0.98	0.77	1.01	4.40	29.51
Filing Date Shares Outstanding	104.08	102.23	96.76	92.3	90.22	4.91
Total Common Shares Outstanding	104.08	102.09	96.72	92.11	89.95	4.91
Working Capital	111.42	135.81	109.16	200.55	311.96	172.75
Book Value Per Share	3.31	3.50	3.36	3.63	3.83	-53.68
Tangible Book Value	-231.98	179.96	141.08	143.44	285.36	-288.01
Tangible Book Value Per Share	-2.23	1.76	1.46	1.56	3.17	-58.66
Machinery	-	2.74	10.35	9.59	8.83	7.75
Leasehold Improvements	-	10.23	12.31	11.72	11.71	11.65

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q